NDC 0009-5137-01 - Zyvox
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0009-5137
- Requested NDC
- 0009-5137-01
- Package NDCs from labels
- 0009-5137-01, 0009-5137-04
- Manufacturer
- Pharmacia & Upjohn Company LLC | Pfizer Asia Manufacturing Pte Ltd | NEOLPHARMA, INC. | Pfizer Manufacturing Deutschland GmbH
- Effective date
- 2026-11-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zyvox | Pharmacia & Upjohn Company LLC | Pfizer Asia Manufacturing Pte Ltd | NEOLPHARMA, INC. | Pfizer Manufacturing Deutschland GmbH | 2026-11-03 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0009-5137-01 | Zyvox | 100 mL in 1 BAG | INJECTION, SOLUTION | 100 | 69 | |
| 0009-5137-04 | Zyvox | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 69 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0009-5137 | ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) GRANULE, FOR SUSPENSION ZYVOX (LINEZOLID) TABLET, FILM COATED [PHARMACIA & UPJOHN COMPANY LLC] | 64 | Legacy NDC, 2 package rows | 20240726_6e70e63b-bfd5-478d-a8ee-8ba22c9efabd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0009-5137-01 | ML - Milliliter | 0009-5137 | 49d3a9c6-6917-4ab9-a783-22b99334ec98 | 1 | 2012-07-24 |
| 0009-5137-04 | ML - Milliliter | 0009-5137 | 21ac320d-3cb2-4a8e-96ba-632c42f28ba3 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sheer Defense Tinted Moisturizer Broad Spectrum SPF 15 MD 70 Merle Norman | OCTINOXATE, TITANIUM DIOXIDE | Merle Norman Cosmetics, Inc. | e12f5324-ed27-4a2e-bf49-f39f7fe351cb | 2026-10-12 | Warnings | 15FIX9V2JP |
| Sheer Defense Tinted Moisturizer SPF 15 ML 30 Merle Norman | OCTINOXATE, TITANIUM DIOXIDE | Merle Norman Cosmetics, Inc. | 0ad4ec84-7c82-4ab3-9070-a0764af12306 | 2026-10-12 | Warnings | 15FIX9V2JP |
| Sheer Defense Tinted Moisturizer SPF 15 ML 40 Merle Norman | OCTINOXATE, TITANIUM DIOXIDE | Merle Norman Cosmetics, Inc. | 02a4e8f6-f257-4d30-8782-64b4d1622d46 | 2026-10-12 | Warnings | 15FIX9V2JP |
| Bare Expert Finish Makeup Broad Spectrum SPF 25 Merle Norman | OCTINOXATE, TITANIUM DIOXIDE | Merle Norman Cosmetics, Inc | ff396aca-cf64-45f8-ba2e-c4fc55d6484b | 2026-10-12 | Warnings | 15FIX9V2JP |
| CC Cream Broad Spectrum SPF 30 Merle Norman | HOMOSALATE, OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE | Merle Norman Cosmetics, Inc | 93ebe819-6763-400c-8320-812276168b6c | 2026-10-12 | Warnings | 15FIX9V2JP |
| Alabaster Beige Perfecting Makeup SPF 25 Merle Norman | OCTINOXATE, TITANIUM DIOXIDE | Merle Norman Cosmetics, Inc | c29cef40-065d-1f8d-e053-2995a90a43e7 | 2026-10-12 | Warnings | 15FIX9V2JP |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 2968PHW8QP |
| Smart Care SPORT ultra SUNSCREEN SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Ashtel Studios Inc. | f1aa4a6b-3be5-4da8-93c0-f195c68da945 | 2026-10-08 | Warnings | 15FIX9V2JP |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| SKIN PHARM mineral tinted spf 44 | TITANIUM DIOXIDE, ZINC OXIDE | Skin Pharm, LLC | 7efa2399-bd24-4361-85fc-70a19edc5629 | 2026-10-08 | Warnings | 15FIX9V2JP |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| VitaPhyte Lubricant Eye Drops | LUBRICANT EYE DROPS | Guangzhou Liyan Cosmetics Technology Co., Ltd. | 5d39f7b1-c0ed-33dc-e063-6394a90aee31 | 2026-10-07 | Warnings | K679OBS311 |
| spf 30 Lip Balm | TITANIUM DIOXIDE | Malin and Goetz Inc | fe1b3122-b6e2-46fa-e053-6394a90afd59 | 2026-10-06 | Warnings | 15FIX9V2JP |
| spf 30 mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Malin and Goetz Inc | f3d39df9-1618-7014-e053-2995a90af7bb | 2026-10-06 | Warnings | 15FIX9V2JP |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.